A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than ...

Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...

A Missouri district court judge on Tuesday said stopping the FTC’s suit against the Big Three PBMs would be “against the ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...